// App-Quantinova.ai

5531 : An international, multicenter, real-world analysis of epithelial ovarian cancer treatment and outcomes.

Researchers

Presenter

  • Geoff Hall

Principal Investigators

  • Sue Cheeseman

  • Bethany Levick

  • Eun Ji Nam

  • Subin Lim

  • Jean-Marc Classe

  • Elodie Martin

  • Paul Kubelac

  • Patriciu Achima?-Cadariu

  • Joana Savva-Bordalo

  • Marina Borges

  • Sven Becker

  • Shabnam Shaid

  • Nicolas Niklas

  • Mariana Guergova-Kuras

Medical Centers

  • HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea

  • Yonsei University Health System, Seoul, Korea

  • Institut de Cancerologie de l'Ouest Paul Papin, Angers, France

  • Prof. Dr. I. Chiricuta Institute of Oncology, Napoca, Romania

  • Portuguese Oncology Institute (IPO-Porto), Porto, Portugal

  • Frankfurt University, Frankfurt, Germany

  • IQVIA Commercial GmbH & Co. OHG, Frankfurt Am Main, Germany

  • IQVIA, La Défense, France

Locations

  • United Kingdom

  • France

  • Romania

  • Portugal

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

  • Breast cancer

Biomarkers

  • BRCA mutation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved